ストックスクリーナーアプリを入手
3.12
1.58%
-0.05
アフターアワーズ：
3.16
0.04
+1.28%
前日終値:
$3.17
開ける：
$3.15
24時間の取引高:
417.89K
Relative Volume:
0.82
時価総額：
$699.94M
収益：
$58.17M
当期純損益:
$-281.50M
株価収益率:
-1.9945
EPS:
-1.5643
ネットキャッシュフロー:
$-349.78M
1週間 パフォーマンス:
+5.41%
1か月 パフォーマンス:
+8.71%
6か月 パフォーマンス:
-8.24%
1年 パフォーマンス:
-25.89%
1日の値動き範囲:
$3.04
$3.2289
1週間の範囲:
$2.93
$3.2289
52週間の値動き範囲:
$2.215
$5.28
Curevac N V Stock (CVAC) Company Profile
CVAC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CVAC
Curevac N V
|
3.12 | 699.94M | 58.17M | -281.50M | -349.78M | -1.2766 |
|
VRTX
Vertex Pharmaceuticals Inc
|
399.35 | 102.84B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.59 | 77.21B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
619.96 | 37.07B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
236.01 | 30.44B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
112.58 | 26.99B | 3.30B | -501.07M | 1.03B | -2.1146 |
Curevac N V Stock (CVAC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-04-25 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2023-06-08 | 開始されました | SVB Securities | Outperform |
| 2023-01-19 | アップグレード | UBS | Neutral → Buy |
| 2023-01-09 | アップグレード | Jefferies | Hold → Buy |
| 2022-01-21 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-01-18 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-10-22 | 開始されました | Deutsche Bank | Hold |
| 2021-06-17 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-04-26 | 再開されました | Credit Suisse | Underperform |
| 2021-04-26 | 開始されました | Guggenheim | Neutral |
| 2020-12-10 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2020-09-08 | 開始されました | BofA Securities | Buy |
| 2020-09-08 | 開始されました | Credit Suisse | Neutral |
| 2020-09-08 | 開始されました | Jefferies | Hold |
すべてを表示
Curevac N V (CVAC) 最新ニュース
CureVac (NASDAQ:CVAC) Stock Quotes, Forecast and News Summary - Benzinga
CureVac (NASDAQ:CVAC) Stock Price Up 3.6%Here's What Happened - MarketBeat
CureVac (NASDAQ:CVAC) Shares Gap DownHere's Why - MarketBeat
CureVac (NASDAQ:CVAC) Trading Up 4.7%What's Next? - MarketBeat
CureVac (NASDAQ:CVAC) Shares Down 5.5%What's Next? - MarketBeat
CureVac's SWOT analysis: mRNA pioneer's stock faces oncology pipeline hurdles - Investing.com
2 Small-Cap Stocks Set to Shine in a Bull Market - Benzinga
CUREVAC : Licensing deal boosts bank account - Marketscreener.com
Point72 Asset Management L.P. Sells 1,642,723 Shares of CureVac (NASDAQ:CVAC) - MarketBeat
CUREVAC : Positive one-off overshadows pipeline dryness - Marketscreener.com
mRNA Therapeutics Market Size to Hit USD 48.65 Billion by 2032 due to Advances in Cancer Treatment and Expanding mRNA Vaccine Applications | Research by SNS Insider - GlobeNewswire Inc.
CureVac NV (XTER:5CV) 50-Day SMA : €2.62 (As of Dec. 05, 2024) - GuruFocus.com
CureVac NV (STU:5CV) 5-Day RSI : 64.31 (As of Dec. 05, 2024) - GuruFocus.com
CureVac's SWOT analysis: mRNA pioneer's stock faces pivotal phase in oncology push - Investing.com
CureVac NV (LTS:0A9E) EBITDA per Share : $0.84 (TTM As of Sep. 2024) - GuruFocus.com
CureVac NV (LTS:0A9E) Profitability Rank : 3 (As of Sep. 2024) - GuruFocus.com
CureVac NV (LTS:0A9E) 3-Year FCF Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
CureVac NV (HAM:5CV) Cyclically Adjusted FCF per Share : €0.00 (As of Sep. 2024) - GuruFocus.com
CureVac NV (WBO:CVAC) Enterprise Value : €94.9 Mil (As of Dec. 01, 2024) - GuruFocus.com
CureVac NV (HAM:5CV) Altman Z-Score : 2.46 (As of Dec. 01, 2024) - GuruFocus.com
CureVac NV (STU:5CV) 3-Year FCF Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
CureVac NV (STU:5CV) Cyclically Adjusted Revenue per Share : €0.00 (As of Sep. 2024) - GuruFocus.com
CVAC (CureVac NV) 9-Day RSI : 62.66 (As of Nov. 30, 2024) - GuruFocus.com
CVACCureVac N.V. Ordinary Shares Latest Stock News & Market Updates - StockTitan
Analysts Are Optimistic We'll See A Profit From CureVac N.V. (NASDAQ:CVAC) - Simply Wall St
CureVac NV (STU:5CV) Total Assets : €854.2 Mil (As of Sep. 2024) - GuruFocus.com
CVAC (CureVac NV) Capex-to-Operating-Cash-Flow : 0.01 (As of Sep. 2024) - GuruFocus.com
Loss-Making CureVac N.V. (NASDAQ:CVAC) Set To Breakeven - Yahoo Finance
Is the Options Market Predicting a Spike in CureVac (CVAC) Stock? - MSN
CureVac NV (STU:5CV) Total Inventories : €0.5 Mil (As of Sep. 2024) - GuruFocus.com
CureVac NV (STU:5CV) 50-Day SMA : €2.65 (As of Nov. 21, 2024) - GuruFocus.com
CureVac NV (XTER:5CV) Float Percentage Of Total Shares Outs - GuruFocus.com
CureVac NV (STU:5CV) Retained Earnings : €-1,371.0 Mil (As of Sep. 2024) - GuruFocus.com
CureVac NV (FRA:5CV) Retained Earnings : €-1,371.0 Mil (As of Sep. 2024) - GuruFocus.com
CureVac NV (FRA:5CV) Free Cash Flow : €94.5 Mil (TTM As of Sep. 2024) - GuruFocus.com
CureVac NV (HAM:5CV) 3-Year Revenue Growth Rate : -16.20% (As of Sep. 2024) - GuruFocus.com
CureVac NV (FRA:5CV) EBITDA : €165.9 Mil (TTM As of Sep. 2024) - GuruFocus.com
CureVac’s stock soars on GSK’s $1.56 billion deal for its COVID-19 and flu vaccines - MSN
10 Best German Stocks To Buy Now - Insider Monkey
Is CureVac N.V. (CVAC) the Best German Stock to Buy Now? - Insider Monkey
CureVac NV (HAM:5CV) 3-Year Dividend Growth Rate : 0.00% (As of Jun. 2024) - GuruFocus.com
CVAC (CureVac NV) Short-Term Capital Lease Obligation : $5.46 Mil (As of Jun. 2024) - GuruFocus.com
mRNA Vaccine and Therapeutics Market 2024-2031: Global - openPR
CureVac NV earnings beat by €0.09, revenue topped estimates - Investing.com Canada
CureVac N.V. (NASDAQ:CVAC) Q3 2024 Earnings Call Transcript - Insider Monkey
CureVac NV (CVAC) Q3 2024 Earnings Call Highlights: Strong Financial Performance and Strategic ... - Yahoo Finance
CureVac Reports Significant Revenue Growth Amid Strategic Restructuring - TipRanks
CureVac Reports Surging Revenues and Profit Growth - TipRanks
CureVac on track with 30% workforce reduction - TipRanks
CureVac reports Q3 revenue EUR 493.9M vs. EUR 16.5M last year - TipRanks
CureVac sees cash runway into 2028 - TipRanks
Curevac N V (CVAC) 財務データ
収益
当期純利益
現金流量
EPS
1.76%
1.06%
大文字化:
|
ボリューム (24 時間):